Technical Analysis for DMAC - DiaMedica Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 2.43 -5.08% -0.13
DMAC closed down 5.08 percent on Monday, August 19, 2019, on 48 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical DMAC trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction -5.08%
Lower Bollinger Band Walk Weakness -5.08%
Stochastic Reached Oversold Weakness -5.08%
Wide Bands Range Expansion -5.08%
Lower Bollinger Band Touch Weakness -5.08%

Older signals for DMAC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for neurological and kidney diseases. The company's lead product is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase II clinical trials for the treatment of acute ischemic stroke and kidney injury indications. It is also developing DM199 for the treatment vascular dementia. In addition, the company is developing DM300, which is in pre-clinical stage for the treatment for acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Kidney Diseases
Is DMAC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.53
52 Week Low 0.2588
Average Volume 144,198
200-Day Moving Average 3.338
50-Day Moving Average 3.7895
20-Day Moving Average 3.2715
10-Day Moving Average 2.935
Average True Range 0.4034
ADX 28.24
+DI 9.7469
-DI 28.0492
Chandelier Exit (Long, 3 ATRs ) 2.7298
Chandelier Exit (Short, 3 ATRs ) 3.4202
Upper Bollinger Band 4.185
Lower Bollinger Band 2.358
Percent B (%b) 0.04
BandWidth 55.845942
MACD Line -0.3543
MACD Signal Line -0.2594
MACD Histogram -0.0949
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.88
Resistance 3 (R3) 2.92 2.81 2.81
Resistance 2 (R2) 2.81 2.70 2.79 2.78
Resistance 1 (R1) 2.62 2.62 2.57 2.58 2.75
Pivot Point 2.51 2.51 2.48 2.49 2.51
Support 1 (S1) 2.32 2.40 2.27 2.28 2.11
Support 2 (S2) 2.21 2.32 2.19 2.08
Support 3 (S3) 2.02 2.21 2.06
Support 4 (S4) 1.98